<DOC>
	<DOC>NCT01953731</DOC>
	<brief_summary>This study will compare the plasma pharmacokinetics of a single 125mg oral dose of palbociclib in the presence and absence of rifampin-mediated enzyme induction in a fixed-sequence two-period study.</brief_summary>
	<brief_title>A Study To Investigate The Drug-Drug Interaction Potential Of Rifampin OnThe Investigational Agent Palbociclib (PD-0332991)</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Palbociclib</mesh_term>
	<criteria>Healthy males or females of nonchildbearing potential body mass index between 17.530.5 kg/m2 with a total body weight greater than 50kg Evidence or history of any clinically significant physiologic, psychological, or medical conditions a positive drug screen or alcohol breath test a baseline ECG demonstrating a QTc&gt;450msecs or a QRS interval &gt;120msecs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>palbociclib</keyword>
	<keyword>PD-0332991</keyword>
	<keyword>rifampin</keyword>
	<keyword>drug-drug interaction study</keyword>
</DOC>